Results 51 to 60 of about 7,353,326 (373)

Flavonoids and Other Polyphenols Act as Epigenetic Modifiers in Breast Cancer. [PDF]

, 2020
Breast cancer is a common cancer that occurs due to different epigenetic alterations and genetic mutations. Various epidemiological studies have demonstrated an inverse correlation between breast cancer incidence and flavonoid intake.
Anwar, Hina, Badgeley, Aja, Lakshmikuttyamma, Ashakumary, Lawrence, Katharine, Murphy, Paige, Selvakumar, Priyanga, Sharma, Urvashi   +6 more
core   +1 more source

Perceptions of Breast Cancer Screening in Older Chinese Women: A Meta-Ethnography [PDF]

, 2014
In Eastern Asia, as the incidence of breast cancer continues to increase yet compliance with breast cancer screening in older Chinese women who are at risk of early stage breast cancer is poor.
Banning, M, Shia, N
core   +1 more source

Cancer statistics, 2023

Ca, 2023
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population‐based cancer occurrence and outcomes using incidence data collected by central cancer ...
R. Siegel, K. D. Miller, N. S. Wagle, A. Jemal   +3 more
semanticscholar   +1 more source

Efficacy and safety of diphereline 11.25 mg, microrelin 11.25 mg, and microrelin 3.75 mg in premenopausal patients with breast cancer: a non-inferiority randomized clinical trial

BMC Cancer, 2023
Background Diphereline is a Gonadotropin-Releasing Hormone agonist commonly used in patients with breast cancer. This study aimed to compare the efficacy and safety of one-month and three-month Microrelin injections produced by Homa Pharmed Company with ...
Safa Najafi, Maryam Ansari, Zahra Omidi, Asiie Olfatbakhsh, Shiva Moghadam, Esmat-o-Sadat Hashemi, Niki Najafi, Shahpar Haghighat   +7 more
doaj   +1 more source

Establishment and Verification of a Predictive Model for Node Pathological Complete Response After Neoadjuvant Chemotherapy for Initial Node Positive Early Breast Cancer

Frontiers in Oncology, 2021
ObjectiveAxillary node status after neoadjuvant chemotherapy (NCT) in early breast cancer patients influences the axillary surgical staging procedure. This study was conducted for the identification of the likelihood of patients being node pathological ...
Jiujun Zhu, Dechuang Jiao, Min Yan, Xiuchun Chen, Chengzheng Wang, Zhenduo Lu, Lianfang Li, Xianfu Sun, Li Qin, Xuhui Guo, Chongjian Zhang, Jianghua Qiao, Jianbin Li, Zhimin Fan, Haibo Wang, Jianguo Zhang, Yongmei Yin, Peifen Fu, Cuizhi Geng, Feng Jin, Zefei Jiang, Shude Cui, Zhenzhen Liu   +22 more
doaj   +1 more source

Impact of breast cancer subtypes on 3-year survival among adolescent and young adult women. [PDF]

, 2013
IntroductionYoung women have poorer survival after breast cancer than do older women. It is unclear whether this survival difference relates to the unique distribution of hormone receptor (HR) and human epidermal growth factor receptor 2 (HER2)-defined ...
Clarke, Christina A, DeRouen, Mindy C, Gomez, Scarlett L, Keegan, Theresa HM, Kurian, Allison W, Press, David J, Tao, Li   +6 more
core   +2 more sources

Amyloid tumor of the breast

Surgical Case Reports, 2019
Background Amyloid tumor of the breast is a rare disease, which was first reported in 1973. To date, only six cases have been reported in Japan. Case presentation A 45-year-old woman who had a medical history of Sjogren’s syndrome presented with a lump ...
Makiko Mori, Haruru Kotani, Masataka Sawaki, Masaya Hattori, Akiyo Yoshimura, Naomi Gondo, Yayoi Adachi, Ayumi Kataoka, Kayoko Sugino, Nanae Horisawa, Mitsuo Terada, Yuri Ozaki, Hiroji Iwata   +12 more
doaj   +1 more source

Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk

Cancer Cell International, 2022
As an intelligent disease, tumors apply several pathways to evade the immune system. It can use alternative routes to bypass intracellular signaling pathways, such as nuclear factor-κB (NF-κB), Wnt, and mitogen-activated protein (MAP)/phosphoinositide 3 ...
Khadijeh Barzaman, Rana Vafaei, Mitra Samadi, Mohammad Hossein Kazemi, Aysooda Hosseinzadeh, Parnaz Merikhian, Shima Moradi-Kalbolandi, Mohammad Reza Eisavand, Houra Dinvari, Leila Farahmand   +9 more
doaj   +1 more source

Supervised risk predictor of breast cancer based on intrinsic subtypes.

Journal of Clinical Oncology, 2009
UNLABELLED PURPOSE To improve on current standards for breast cancer prognosis and prediction of chemotherapy benefit by developing a risk model that incorporates the gene expression-based "intrinsic" subtypes luminal A, luminal B, HER2-enriched, and ...
J. Parker, Michael Mullins, M. Cheang, S. Leung, D. Voduc, T. Vickery, S. Davies, C. Fauron, Xiaping He, Zhiyuan Hu, J. Quackenbush, I. Stijleman, J. Palazzo, J. Marron, A. Nobel, E. Mardis, T. Nielsen, M. Ellis, C. Perou, P. Bernard   +19 more
semanticscholar   +1 more source

A gene-expression signature as a predictor of survival in breast cancer.

New England Journal of Medicine, 2002
BACKGROUND A more accurate means of prognostication in breast cancer will improve the selection of patients for adjuvant systemic therapy. METHODS Using microarray analysis to evaluate our previously established 70-gene prognosis profile, we classified
M. J. van de Vijver, Yudong He, L. J. van ’t Veer, H. Dai, A. Hart, D. Voskuil, G. Schreiber, J. Peterse, C. Roberts, M. Marton, M. Parrish, D. Atsma, A. Witteveen, A. Glas, L. Delahaye, Tony van der Velde, H. Bartelink, S. Rodenhuis, E. Rutgers, S. Friend, René Bernards   +20 more
semanticscholar   +1 more source